In order to test this hypothesis, we analyzed CpG5 methylation levels in melanoma cell lines (N = 59), cell lines of melanocytes (N = 3), and peripheral leukocytes (monocytes, B cells, CD8+ and CD4+ T cells) from healthy donors (N = 28). This evidence concerns the gene CD4 and melanoma.